XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.20.2

Accrued Expenses | 6 Months Ended
--- | ---
Jun. 30, 2020
Payables And Accruals [Abstract] |
Accrued Expenses | 7. Accrued Expenses Accrued expenses consist of the following:
|  | June 30, 2020 |  |  | December 31, 2019 |
Accrued clinical trial costs |  | $ | 1,919 |  |  | $ | 9,866 |
Accrued payroll and bonus expenses |  |  | 838 |  |  |  | 1,207 |
Accrued manufacturing expenses |  |  | 136 |  |  |  | 136 |
Accrued other expenses |  |  | 1,055 |  |  |  | 1,249 |
Total |  | $ | 3,948 |  |  | $ | 12,458 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration